Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentaur Regulatory News (CAU)

  • There is currently no data for CAU

Form 8.3 - Centaur Media plc

26 Sep 2013 16:42

Phoenix Fund Services (UK) Limited - Form 8.3 - Centaur Media plc

Phoenix Fund Services (UK) Limited - Form 8.3 - Centaur Media plc

PR Newswire

London, September 26

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Identity of the person whose positions/ Phoenix Fund Services (UK)dealings are being disclosed: Limited on behalf of Chelverton Asset Management Limited (b) Owner or controller of interests and shortpositions disclosed, if different from 1(a): The naming of nominee or vehicle companies isinsufficient (c) Name of offeror/offeree in relation to Centaur Media Plcwhose relevant securities this form relates: Use a separate form for each offeror/offeree (d) If an exempt fund manager connected withan offeror/offeree, state this and specifyidentity of offeror/offeree: (e) Date position held: 25th September 2013 (f) Has the discloser previously disclosed, or Noare they today disclosing, under the Code inrespect of any other party to this offer? 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE (a) Interests and short positions in the relevant securities of the offeror orofferee to which the disclosure relates following the dealing (if any) Class of relevant security: Ordinary 10p Interests Short positions Number % Number % (1) Relevant securities owned 3,228,345 2.259% 0 0and/or controlled: (2) Derivatives (other than 0 0 0 0options): (3) Options and agreements to 0 0 0 0purchase/sell: TOTAL: 3,228,345 2.259% 0 0 All interests and all short positions should be disclosed. Details of any open derivative or option positions, or agreements to purchaseor sell relevant securities, should be given on a Supplemental Form 8 (OpenPositions). (b) Rights to subscribe for new securities (including directors' and otherexecutive options) Class of relevant security in N/Arelation to which subscription rightexists: Details, including nature of the N/Arights concerned and relevantpercentages: If there are positions or rights to subscribe to disclose in more than oneclass of relevant securities of the offeror or offeree named in 1(c), copytable 2(a) or (b) (as appropriate) for each additional class of relevantsecurity. 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (a) Purchases and sales Class of relevant Purchase/sale Number of Price per unit security securities N/A (b) Derivatives transactions (other than options) Class of Product Nature of dealing Number of Price per relevant description reference unit security e.g. opening/closing a securities e.g. CFD long/short position, increasing/reducing a long/short position N/A (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Class of Product Writing, Number of Exercise Type Expiry Optionrelevant description purchasing, securities price date moneysecurity e.g. call selling, to which per unit e.g. paid/ option varying option American, received etc. relates European per unit etc. N/A (ii) Exercising Class of relevant Product Number of Exercise price per security description securities unit e.g. call option N/A (d) Other dealings (including subscribing for new securities) Class of relevant Nature of dealing Details Price per unit security (if applicable) e.g. subscription, conversion N/A The currency of all prices and other monetary amounts should be stated. Where there have been dealings in more than one class of relevant securities ofthe offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (asappropriate) for each additional class of relevant security dealt in. 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement orunderstanding, formal or informal, relating to relevant securities which maybe an inducement to deal or refrain from dealing entered into by the personmaking the disclosure and any party to the offer or any person acting inconcert with a party to the offer: If there are no such agreements, arrangements or understandings, state "none" None (b) Agreements, arrangements or understandings relating to options orderivatives Details of any agreement, arrangement or understanding, formal or informal,between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevantsecurities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none" None (c) Attachments Is a Supplemental Form 8 (Open Positions) attached? NO Date of disclosure: 25th September 2013 Contact name: George Bayer Telephone number: 01245 398984 Public disclosures under Rule 8 of the Code must be made to a RegulatoryInformation Service and must also be emailed to the Takeover Panel atmonitoring@disclosure.org.uk . The Panel's Market Surveillance Unit isavailable for consultation in relation to the Code's dealing disclosurerequirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .

Date   Source Headline
23rd Aug 202110:57 amRNSDirector/PDMR Shareholding
3rd Aug 20211:20 pmRNSBoard Update
29th Jul 20213:25 pmRNSDirector Declaration – William Eccleshare
21st Jul 20217:00 amRNSHalf-year Report
20th Jul 20214:38 pmRNSDirector/PDMR Shareholding
22nd Jun 20214:35 pmRNSDirector/PDMR Shareholding
7th Jun 20213:00 pmRNSCentaur announces management changes at The Lawyer
12th May 20214:57 pmRNSResult of AGM
19th Apr 20213:13 pmRNSDirector/PDMR Shareholding
30th Mar 20211:55 pmRNSAnnual Financial Report
25th Mar 20213:53 pmRNSDirector/PDMR Shareholding
23rd Mar 20218:14 amRNSDirector/PDMR Shareholding
17th Mar 20217:00 amRNSPreliminary results year ended 31 December 2020
5th Mar 20219:02 amRNSHolding(s) in Company
5th Mar 20219:00 amRNSHolding(s) in Company
23rd Feb 20217:00 amRNSAppointment of Financial Adviser and Joint Broker
22nd Feb 20211:28 pmRNSDirector/PDMR Shareholding
27th Jan 20217:00 amEQSEdison Investment Research Limited: Centaur Media (LON:CAU): Initiation - Flagships lead the way
26th Jan 202110:30 amRNSInitiation of Coverage: Edison Investment Research
26th Jan 20217:00 amRNSTrading update
22nd Jan 202111:09 amRNSHolding(s) in Company
20th Jan 202110:46 amRNSDirector/PDMR Shareholding
22nd Dec 20202:42 pmRNSDirector/PDMR Shareholding
23rd Nov 202012:54 pmRNSDirector/PDMR Shareholding
18th Nov 202011:27 amRNSAppointment of new auditor
28th Oct 20207:00 amRNS2020 trading update and full-year outlook
21st Oct 202010:19 amRNSDirector/PDMR Shareholding
19th Oct 20209:12 amRNSHolding(s) in Company
14th Oct 20207:00 amRNSFCA grants temporary modification to free float
22nd Sep 20202:41 pmRNSDirector/PDMR Shareholding
26th Aug 20209:23 amRNSHolding(s) in Company
24th Aug 202012:03 pmRNSDirector/PDMR Shareholding
23rd Jul 20207:00 amRNSInvestor Presentation
21st Jul 20201:38 pmRNSDirector/PDMR Shareholding
21st Jul 20207:00 amRNSInterim results for the 6 months ended 30 Jun 2020
30th Jun 20202:30 pmRNSDirector/PDMR Shareholding
30th Jun 202010:32 amRNSResult of AGM
30th Jun 20207:00 amRNSHolding(s) in Company
23rd Jun 202012:38 pmRNSDirector/PDMR Shareholding
17th Jun 20207:00 amRNSTotal Voting Rights
29th May 20208:31 amRNSHolding(s) in Company
29th May 20208:29 amRNSHolding(s) in Company
27th May 20208:25 amRNSTrading update, suspension of dividend and AGM
20th May 20202:11 pmRNSDirector/PDMR Shareholding
14th May 20202:59 pmRNSDirector/PDMR Shareholding
30th Apr 20202:39 pmRNSDirector/PDMR Shareholding
30th Apr 20207:00 amRNSDirector/PDMR Shareholding
9th Apr 202011:30 amRNSDirector/PDMR Shareholding
8th Apr 20207:00 amRNSCOVID-19 update
1st Apr 20207:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.